HAEMONETICS CORP/MASS (HAE)

US4050241003 - Common Stock

85.43  +0.51 (+0.6%)

After market: 85.43 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
993.2M
14.10%
1.169B
17.67%
1.309B
12.01%
1.41B
7.71%
EBITDA
YoY % growth
198.3M
25.59%
261.5M
31.87%
310.449M
18.72%
424.18M
36.63%
EBIT
YoY % growth
100.6M
36.68%
168.2M
67.20%
213.234M
26.77%
329.48M
54.52%
Operating Margin
10.13%14.39%16.29%23.37%
EPS
YoY % growth
2.59
10.21%
3.03
16.99%
3.98
31.35%
4.63
16.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.21
16.73%
Revenue
Q2Q % growth
360.43M
7.19%
EBITDA
Q2Q % growth
105.84M
-17.70%
EBIT
Q2Q % growth
87.57M
48.36%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.12
13.13%
1.080.043.35%
Q1 2025
Q2Q % growth
1.02
-2.86%
1.020.000.44%
Q4 2024
Q2Q % growth
0.90
16.88%
0.900.00-0.02%
Q3 2024
Q2Q % growth
1.04
22.35%
0.950.099.38%
Q2 2024
Q2Q % growth
Q1 2024
Q2Q % growth
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
345.511M
8.59%
346.07M-559K-0.16%
Q1 2025
Q2Q % growth
336.172M
7.98%
338.73M-2.558M-0.76%
Q4 2024
Q2Q % growth
343.29M
12.77%
332.4M10.89M3.28%
Q3 2024
Q2Q % growth
336.25M
10.14%
323.5M12.75M3.94%
Q2 2024
Q2Q % growth
Q1 2024
Q2Q % growth
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.4% -2.4% -0.4% -0.16%
Revenue-0.55% -0.55% -0.07% -0.28%